uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cardiac remodeling in obesity and after bariatric and metabolic surgery; is there a role for gastro-intestinal hormones?
Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands.
Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands.
Onze Lieve Vrouw Hosp, Dept Cardiothorac Surg, Amsterdam, Netherlands.
Metab Surg Clin, Dept Bariatr & Metab Surg, Sisli, Turkey.
Show others and affiliations
2019 (English)In: Expert Review of Cardiovascular Therapy, ISSN 1477-9072, E-ISSN 1744-8344, Vol. 17, no 11, p. 771-790Article, review/survey (Refereed) Published
Abstract [en]

Introduction: Obesity is associated with various diseases such as type 2 diabetes, hypertension, obstructive sleep apnea syndrome (OSAS), metabolic syndrome, and cardiovascular diseases. It affects several organ systems, including the pulmonary and cardiac systems. Furthermore, it induces pulmonary and cardiac changes that can result in right and/or left heart failure. Areas covered: In this review, authors provide an overview of obesity and cardiovascular remodeling, the individual actions of the gut hormones (like GLP-1 and PYY), the effects after bariatric/metabolic surgery and its influence on cardiac remodeling. In this review, we focussed and searched for literature in Pubmed and The Cochrane library (from the earliest date until April 2019), regarding cardiac function changes before and after bariatric surgery and literature regarding changes in gastrointestinal hormones. Expert opinion: Regarding the surgical treatment of obesity and metabolic diseases there is recognition of the importance of both weight loss (bariatric surgery) and improvement in metabolic milieu (metabolic surgery). A growing body of evidence further suggests that bariatric surgical procedures [like the Sleeve Gastrectomy (SG), Roux-en Y Gastric Bypass (RYGB), or One Anastomosis Gastric Bypass (OAGB)] have can improve outcomes of patients suffering from a number of cardiovascular diseases, including heart failure.

Place, publisher, year, edition, pages
2019. Vol. 17, no 11, p. 771-790
Keywords [en]
Gastro-intestinal hormones, GLP-1, PYY, bariatric surgery, metabolic surgery, cardiac remodeling
National Category
Endocrinology and Diabetes Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:uu:diva-407165DOI: 10.1080/14779072.2019.1690991ISI: 000498647800001PubMedID: 31746657OAI: oai:DiVA.org:uu-407165DiVA, id: diva2:1415916
Available from: 2020-03-20 Created: 2020-03-20 Last updated: 2020-03-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Sundbom, Magnus

Search in DiVA

By author/editor
Sundbom, Magnus
By organisation
Upper Abdominal Surgery
In the same journal
Expert Review of Cardiovascular Therapy
Endocrinology and DiabetesGastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf